X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BCTX

Closed

Briacell Therapeutics Corp

2.86
-0.08 (-2.72%)
Last Update: 01 Jul 2025 23:02:00
Yesterday: 2.94
Day's Range: 2.85 - 2.95
Send
When Written:
 
7.45
BriaCell Therapeutics Corp is a clinical-stage biotechnology company that develops targeted immunotherapies for advanced breast cancer and other cancers. The company's lead product candidate, Bria-IMT, is a personalized immunotherapy that targets cancer cells while sparing healthy cells. BriaCell also has a second product candidate, Bria-OTS, which is a off-the-shelf immunotherapy that is designed to work in combination with Bria-IMT.

BriaCell's immunotherapies are based on a proprietary technology platform that leverages the patient's own immune system to fight cancer. The company's approach is to stimulate an immune response against cancer cells by exposing the patient's immune system to cancer-specific antigens. This approach has the potential to be more effective and less toxic than traditional chemotherapy and radiation therapy.

BriaCell is headquartered in Berkeley, California, and has additional operations in Vancouver, British Columbia. The company was founded in 2014 and went public in 2017.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X